Sponsor Pipeline

Xingjun Guo Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07561775 Adebrelimab Plus S-1 for Resected Cholangiocarcinoma Cholangiocarcinoma Not Yet Recruiting
Disease Areas
Cholangiocarcinoma (1)
Get alerts when Xingjun Guo's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free